A detailed history of Promethium Advisors,Llc transactions in Abbott Laboratories stock. As of the latest transaction made, Promethium Advisors,Llc holds 3,104 shares of ABT stock, worth $351,652. This represents 0.25% of its overall portfolio holdings.

Number of Shares
3,104
Holding current value
$351,652
% of portfolio
0.25%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $310,617 - $366,675
3,104 New
3,104 $354 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Promethium Advisors,Llc Portfolio

Follow Promethium Advisors,Llc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Promethium Advisors,Llc, based on Form 13F filings with the SEC.

News

Stay updated on Promethium Advisors,Llc with notifications on news.